Lingqun Ye

1.7k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Lingqun Ye is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Lingqun Ye has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Oncology. Recurrent topics in Lingqun Ye's work include Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers) and Congenital heart defects research (4 papers). Lingqun Ye is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers) and Congenital heart defects research (4 papers). Lingqun Ye collaborates with scholars based in China, United States and Denmark. Lingqun Ye's co-authors include Liuling Xiao, Su Pan, Qing Yi, Jianfei Qian, Qiang Wang, Maojie Yang, Enguang Bi, Lintao Liu, Xingzhe Ma and Yuguan Ze and has published in prestigious journals such as Nature Communications, Blood and Nature Biotechnology.

In The Last Decade

Lingqun Ye

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

2021 664 citations Xingzhe Ma, Liuling Xiao et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingqun Ye China	15	605	422	356	265	255	30	1.2k
Zhi‐Ling Li China	16	859 1.4×	485 1.1×	468 1.3×	250 0.9×	341 1.3×	40	1.4k
Zhengsheng Wu China	22	970 1.6×	667 1.6×	127 0.4×	174 0.7×	376 1.5×	43	1.5k
Ming Zhong China	20	838 1.4×	571 1.4×	104 0.3×	187 0.7×	382 1.5×	56	1.4k
Jen‐Yu Hung Taiwan	18	788 1.3×	570 1.4×	363 1.0×	276 1.0×	439 1.7×	46	1.4k
Xiaoyi Wang China	18	549 0.9×	298 0.7×	114 0.3×	120 0.5×	182 0.7×	39	918
Crina Tiron Romania	12	552 0.9×	186 0.4×	105 0.3×	407 1.5×	540 2.1×	27	1.3k
Junyao Yang China	18	719 1.2×	487 1.2×	116 0.3×	306 1.2×	269 1.1×	41	1.3k
Xiaoming Dai China	19	830 1.4×	252 0.6×	140 0.4×	223 0.8×	320 1.3×	38	1.5k
Lini Chen China	11	574 0.9×	386 0.9×	377 1.1×	60 0.2×	162 0.6×	19	939

Countries citing papers authored by Lingqun Ye

Since Specialization

Citations

This map shows the geographic impact of Lingqun Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingqun Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingqun Ye more than expected).

Fields of papers citing papers by Lingqun Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingqun Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingqun Ye. The network helps show where Lingqun Ye may publish in the future.

Co-authorship network of co-authors of Lingqun Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Lingqun Ye. A scholar is included among the top collaborators of Lingqun Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingqun Ye. Lingqun Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Liuling, Rui Duan, Chuanchao Zhang, et al.. (2025). Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss. Nature Cancer. 6(4). 718–735. 2 indexed citations

Ye, Lingqun, et al.. (2025). Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases. Journal of Translational Medicine. 23(1). 380–380. 7 indexed citations

Xian, Miao, Qiang Wang, Liuling Xiao, et al.. (2024). Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nature Communications. 15(1). 5767–5767. 15 indexed citations

Li, Jingxian, Lingqun Ye, Hui Gong, et al.. (2024). Generation of human induced pluripotent stem cell line from a patient with restrictive cardiomyopathy. Stem Cell Research. 76. 103370–103370. 2 indexed citations

Han, Xinglong, Lina Qu, Miao Yu, et al.. (2024). Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity. Signal Transduction and Targeted Therapy. 9(1). 86–86. 17 indexed citations

Li, Shengyu, Pengzhi Zhang, Lingqun Ye, et al.. (2023). A relay velocity model infers cell-dependent RNA velocity. Nature Biotechnology. 42(1). 99–108. 48 indexed citations

Ye, Lingqun, Mingshan Wang, Jin-Jin Zhang, et al.. (2022). Unveiling the functional and evolutionary landscape of RNA editing in chicken using genomics and transcriptomics. 动物学研究. 43(6). 1011–1022. 4 indexed citations

Gao, Yuhan, Jingcao Huang, Zhuang Yang, et al.. (2022). ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5. JCI Insight. 7(19). 6 indexed citations

Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations

10.

Ni, Xuan, Lingqun Ye, Xinglong Han, et al.. (2021). Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells. Acta Pharmacologica Sinica. 43(1). 240–250. 7 indexed citations

11.

Wang, Yong, Wei Lei, Xuan Ni, et al.. (2021). The updated view on induced pluripotent stem cells for cardiovascular precision medicine. Pflügers Archiv - European Journal of Physiology. 473(7). 1137–1149. 3 indexed citations

12.

Yu, Miao, Xinglong Han, Lingqun Ye, Wei Lei, & Shijun Hu. (2021). Generation of Human Induced Pluripotent Stem Cells from Renal Epithelial Cells. Methods in molecular biology. 2549. 299–305. 2 indexed citations

13.

Jiang, Xue, Yihuan Chen, Xiaofeng Liu, et al.. (2021). Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells. Frontiers in Cell and Developmental Biology. 9. 672039–672039. 7 indexed citations

14.

Ma, Xingzhe, Liuling Xiao, Lintao Liu, et al.. (2021). CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metabolism. 33(5). 1001–1012.e5. 664 indexed citations breakdown →

15.

Li, Peishun, Daniel Sundh, Boyang Ji, et al.. (2021). Metabolic Alterations in Older Women With Low Bone Mineral Density Supplemented With Lactobacillus reuteri. JBMR Plus. 5(4). e10478–e10478. 30 indexed citations

16.

Liu, Lintao, Enguang Bi, Xingzhe Ma, et al.. (2020). Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9. Nature Communications. 11(1). 5902–5902. 72 indexed citations

17.

Miao, Shumei, Dandan Zhao, Xiaoxiao Wang, et al.. (2020). Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes. Theranostics. 10(21). 9686–9701. 34 indexed citations

18.

You, Yu, Jingjing Li, Xinglong Han, et al.. (2019). Human embryonic stem cell-derived cardiomyocyte therapy in mouse permanent ischemia and ischemia-reperfusion models. Stem Cell Research & Therapy. 10(1). 167–167. 29 indexed citations

19.

Ye, Lingqun, Xuan Ni, Zhen‐Ao Zhao, Wei Lei, & Shijun Hu. (2018). The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing. Journal of Cardiovascular Translational Research. 11(5). 366–374. 20 indexed citations

20.

Xu, Haibo, Mingshan Wang, Newton O. Otecko, et al.. (2017). Annotating long intergenic non-coding RNAs under artificial selection during chicken domestication. BMC Evolutionary Biology. 17(1). 192–192. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact